We are Intignus Biotech
What are we doing?
We understand that early diagnosis of pregnancy-related disorders is a significant, yet unmet need for expecting mothers globally. At Intignus, a team of trained nanotechnologists, molecular biologists and clinical research experts are working towards solving these problems. We have developed rapid point-of-care tests for early diagnosis of diseases such as preeclampsia and premature labor, among others. Our other products are prenatal genetic screening tests that provide information regarding maternal and fetal wellness. These products can help clinicians identify high-risk women and will allow intensive antenatal surveillance and subsequent prophylactic interventions for healthier pregnancies. Our endeavor is supported by a distinguished team of clinicians and scientists. Founded in 2018, we are currently based at a technology incubator in Pune.